1,079 followers
RT @NatRevRheumatol: Secukinumab inhibits joint structural damage in active psoriatic #arthritis through 52 weeks - new study in A&R https…
RT @NatRevRheumatol: Secukinumab inhibits joint structural damage in active psoriatic #arthritis through 52 weeks - new study in A&R https…
RT @NatRevRheumatol: Secukinumab inhibits joint structural damage in active psoriatic #arthritis through 52 weeks - new study in A&R https…
Secukinumab Provides Significant & Sustained Inhibition of Joint Structural Damage in Phase III Study of Active PsA https://t.co/Yfo5QDPvuH
RT @NatRevRheumatol: Secukinumab inhibits joint structural damage in active psoriatic #arthritis through 52 weeks - new study in A&R https…